| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 400.68M | 372.69M | 354.86M | 286.19M | 226.74M |
| Gross Profit | 221.44M | 209.96M | 213.11M | 162.24M | 103.92M |
| EBITDA | 219.53M | 197.29M | 209.19M | 152.80M | 83.94M |
| Net Income | 162.57M | 153.21M | 148.03M | 85.01M | 38.68M |
Balance Sheet | |||||
| Total Assets | 1.60B | 1.59B | 1.46B | 1.41B | 1.20B |
| Cash, Cash Equivalents and Short-Term Investments | 250.80M | 273.87M | 215.71M | 199.85M | 156.31M |
| Total Debt | 180.57M | 311.01M | 339.95M | 401.29M | 389.66M |
| Total Liabilities | 494.69M | 648.53M | 674.70M | 772.22M | 649.93M |
| Stockholders Equity | 1.10B | 937.91M | 784.70M | 636.67M | 551.66M |
Cash Flow | |||||
| Free Cash Flow | 111.31M | 97.50M | 96.36M | 58.63M | 37.70M |
| Operating Cash Flow | 198.54M | 205.69M | 237.36M | 212.00M | 119.35M |
| Investing Cash Flow | -137.00M | -108.18M | -140.99M | -153.37M | -76.66M |
| Financing Cash Flow | -127.18M | -41.77M | -81.75M | -19.67M | -37.75M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | HK$3.34B | 5.81 | 15.20% | ― | 7.50% | 5.93% | |
70 Outperform | HK$612.00M | 1.92 | 7.04% | ― | 12.52% | -33.22% | |
63 Neutral | HK$715.82M | 2.52 | 8.40% | 11.09% | 1.47% | 1.93% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
51 Neutral | HK$233.45M | -0.62 | -3.49% | 11.00% | 15.94% | -168.02% | |
42 Neutral | HK$506.13M | -0.23 | -15.64% | 5.30% | -15.33% | -64500.00% |